Search for: "Miceli v Miceli"
Results 21 - 40
of 218
Sort by Relevance
|
Sort by Date
17 Jul 2022, 2:22 pm
Livingston v. [read post]
25 Apr 2022, 4:29 am
ExeGi Pharma, LLC v. [read post]
31 Mar 2022, 1:01 am
The Supreme Court case, Diamond v. [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
10 Aug 2021, 1:18 pm
California Chamber of Commerce v. [read post]
18 Jul 2021, 4:05 pm
Research and Resources How Data Can Be Used Against People: A Classification of Personal Data Misuses, Jacob Leon Kröger, Milagros Miceli and Florian Müller, Technische Universität Berlin, Technische Universität Berlin; Weizenbaum Institute for the Networked Society and Universität Kassel. [read post]
14 Jul 2021, 1:04 am
The Board of Appeal, however, noted the correlation between the titre of the anti-α-SN antibodies present in the tissue of the mice and the average reduction in α-SN aggregates in the mice. [read post]
28 Jun 2021, 12:35 pm
In this case, Miceli recommended to the court that he be given the authority to decide whether S.T. [read post]
28 Apr 2021, 6:18 pm
If cleaning products are provided to the public (e.g., airline passengers), only products compatible with BiaXamTM B110-V and BiaXamTM B110-P should be provided. [read post]
29 Jan 2021, 7:20 am
Or, as the judge put it at paragraph 257, “the fact that one could say that the claim [in Regeneron] covered mice with different lengths of tail but the patent had not enabled how to do what it taught with mice with all possible lengths of tail, did not matter because tail length was not a relevant range”. [read post]
23 Dec 2020, 5:31 am
The main course – Supreme Court cases (7) Modified Mouse Surprise In Regeneron Pharmaceuticals v Kymab [2020] UKSC 27, the UK Supreme Court reviewed the principle of general application in relation to Regeneron’s patents for the creation of a range of types of transgenic mice that produce chimeric antibodies. [read post]
29 Oct 2020, 10:56 am
In Regeneron Pharmaceuticals Inc v. [read post]
6 Oct 2020, 11:11 am
Baker v. [read post]
19 Aug 2020, 12:40 am
This Kat has sufficiency (of mice) objectionsWelcome to the latest IPKat roundup, which should especially cheer fans of patent news and views.PatentsKodak's most recent endeavours, by way of an announced pivot to generic pharmaceutical manufacturing thanks to a US government COVID-response loan, swiftly followed by an insider trading investigation which put the loan on hold, drew comment from PermaKat Neil Wilkof.In news from Australia, GuestKat Rose Hughes reported on the confirmation… [read post]
16 Aug 2020, 5:45 pm
A recent decision by the Supreme Court of Nova Scotia in Downey v. [read post]
14 Jul 2020, 2:48 pm
., Inc. v. [read post]
7 Jul 2020, 11:08 am
by Dennis Crouch Regeneron Pharmaceuticals Inc. v Kymab Ltd. [read post]
2 Jul 2020, 6:13 am
EP ‘287 and EP ‘163 concern methods for producing mice having a reverse chimeric human-mouse locus, and mice made in that way. [read post]
The essential role of animal studies in expediating medical research to battle the COVID-19 pandemic
1 Jul 2020, 9:57 am
v=n7ii9WTDb9E). [read post]
24 Jun 2020, 1:15 pm
(Regeneron Pharmaceuticals Inc v Kymab Ltd. [2020] UKSC 27.) [read post]
